Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
US Department of Justice
Farmers Insurance
Citi
QuintilesIMS
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
Colorcon
Federal Trade Commission

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206316

« Back to Dashboard

NDA 206316 describes SAVAYSA, which is a drug marketed by Daiichi Sankyo Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the SAVAYSA profile page.

The generic ingredient in SAVAYSA is edoxaban tosylate. One supplier is listed for this compound. Additional details are available on the edoxaban tosylate profile page.
Summary for 206316
Tradename:SAVAYSA
Applicant:Daiichi Sankyo Inc
Ingredient:edoxaban tosylate
Patents:2
Pharmacology for NDA: 206316
Mechanism of ActionFactor Xa Inhibitors
Suppliers and Packaging for NDA: 206316
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SAVAYSA edoxaban tosylate TABLET;ORAL 206316 NDA Daiichi Sankyo, Inc. 65597-201 65597-201-70 7 TABLET, FILM COATED in 1 BLISTER PACK (65597-201-70)
SAVAYSA edoxaban tosylate TABLET;ORAL 206316 NDA Daiichi Sankyo, Inc. 65597-201 65597-201-30 30 TABLET, FILM COATED in 1 BOTTLE (65597-201-30)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 15MG BASE
Approval Date:Jan 8, 2015TE:RLD:Yes
Regulatory Exclusivity Expiration:Jan 8, 2020
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:➤ SubscribePatent Expiration:Jun 12, 2023Product Flag?Substance Flag?YDelist Request?
Patent:➤ SubscribePatent Expiration:Mar 28, 2028Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Chinese Patent Office
US Department of Justice
US Army
Dow
Accenture
Chubb
Federal Trade Commission
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot